Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.

Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.

Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schröder JK, Bardenheuer W, Seeber S, Huebner K, Schütte J, Opalka B.

Cancer Res. 2000 Jun 1;60(11):2780-5.

2.

Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells.

Wu R, Connolly DC, Dunn RL, Cho KR.

J Natl Cancer Inst. 2000 Feb 16;92(4):338-44.

3.

Replacement of Fhit in cancer cells suppresses tumorigenicity.

Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM, Huebner K.

Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13771-6.

4.

Novel tumor suppressor locus in human chromosome region 3p14.2.

Jülicher K, Marquitan G, Werner N, Bardenheuer W, Vieten L, Bröcker F, Topal H, Seeber S, Opalka B, Schütte J.

J Natl Cancer Inst. 1999 Sep 15;91(18):1563-8.

6.

Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.

Ishii H, Dumon KR, Vecchione A, Trapasso F, Mimori K, Alder H, Mori M, Sozzi G, Baffa R, Huebner K, Croce CM.

Cancer Res. 2001 Feb 15;61(4):1578-84.

7.

Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.

Sükösd F, Kuroda N, Beothe T, Kaur AP, Kovacs G.

Cancer Res. 2003 Jan 15;63(2):455-7.

9.

FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.

Bugert P, Wilhelm M, Kovacs G.

Genes Chromosomes Cancer. 1997 Sep;20(1):9-15.

PMID:
9290948
10.

Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.

Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Muñoz N, Bosch FX, Shah K, Cho KR.

Cancer Res. 1997 Nov 1;57(21):4692-8.

11.

A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma.

Poland KS, Azim M, Folsom M, Goldfarb R, Naeem R, Korch C, Drabkin HA, Gemmill RM, Plon SE.

Genes Chromosomes Cancer. 2007 Sep;46(9):805-12.

PMID:
17539022
12.
13.

Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.

Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F, Maher ER.

Cancer Res. 2001 Oct 1;61(19):7277-81.

14.

Absence or reduction of Fhit expression in most clear cell renal carcinomas.

Hadaczek P, Siprashvili Z, Markiewski M, Domagala W, Druck T, McCue PA, Pekarsky Y, Ohta M, Huebner K, Lubinski J.

Cancer Res. 1998 Jul 15;58(14):2946-51.

15.

The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control.

Sard L, Accornero P, Tornielli S, Delia D, Bunone G, Campiglio M, Colombo MP, Gramegna M, Croce CM, Pierotti MA, Sozzi G.

Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8489-92.

16.
17.

Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12.

Lott ST, Lovell M, Naylor SL, Killary AM.

Cancer Res. 1998 Aug 15;58(16):3533-7.

18.

[Development of human renal cell carcinoma (RCC)--the responsible genes for the development of hereditary and sporadic human RCCs].

Shuin T, Kamata M, Ashida S.

Gan To Kagaku Ryoho. 2002 Oct;29(10):1719-25. Japanese.

PMID:
12402420
19.

Fragile histidine triad gene expression in primary prostate cancer and in an in vitro model.

Guo Z, Johansson SL, Rhim JS, Vishwanatha JK.

Prostate. 2000 May 1;43(2):101-10.

PMID:
10754525
20.

Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.

Roz L, Gramegna M, Ishii H, Croce CM, Sozzi G.

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3615-20. Epub 2002 Mar 12.

Items per page

Supplemental Content

Write to the Help Desk